99% Savings - Buy Just @1 Rs X
Nitrofix SR 30 Tablet is a commercial drug that is prescribed in the form of Tablet. Primarily, it is used for the treatment of Angina.
The optimal dosage of Nitrofix SR 30 Tablet is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
Nitrofix SR 30 Tablet also has some side effects, the most common being Headache, Dizziness, Flushing. Apart from the aforementioned side effects, Nitrofix SR 30 Tablet can also lead to other problems, which have been listed below. Normally, these side effects of Nitrofix SR 30 Tablet are not long lasting and go away when the treatment is finished. However, if these continue for a longer time, consult your doctor right away.
Furthermore, you should know that effect of Nitrofix SR 30 Tablet is Mild for pregnant women and Mild for women who are breastfeeding. It is important to know if Nitrofix SR 30 Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Nitrofix SR 30 Tablet related warnings section.
Nitrofix SR 30 Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Low Blood Pressure (Hypotension), Anemia are examples of such conditions. The section on Nitrofix SR 30 Tablet contraindications lists all such conditions.
Drug reaction of Nitrofix SR 30 Tablet with other medicines has been reported. Refer to the list below for further details.
You should also be aware that Nitrofix SR 30 Tablet is not safe while driving, and is not addiction.
Nitrofix SR 30 Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Nitrofix SR 30 Tablet safe for pregnant women?
Nitrofix rarely shows harmful effects in in pregnant ladies. Even if it does, the effects are mild
Is the use of Nitrofix SR 30 Tablet safe during breastfeeding?
Side effects of Nitrofix on breastfeeding women are very mild.
What is the effect of Nitrofix SR 30 Tablet on the Kidneys?
Nitrofix is completely safe for kidneys.
What is the effect of Nitrofix SR 30 Tablet on the Liver?
Nitrofix is completely safe for the liver.
What is the effect of Nitrofix SR 30 Tablet on the Heart?
Nitrofix is rarely harmful for the heart.
If you are suffering from any of the following diseases, you should not take Nitrofix SR 30 Tablet unless your doctor advises you to do so -
Is this Nitrofix SR 30 Tablet habit forming or addictive?
Nitrofix SR 30 Tablet is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Nitrofix SR 30 Tablet. So it is best to avoid driving.
Is it safe?
Nitrofix SR 30 Tablet should be used only after doctor's advice.
Is it able to treat mental disorders?
No, Nitrofix SR 30 Tablet is not used to treat mental disorders.
Interaction between Food and Nitrofix SR 30 Tablet
Due to the absence of research, it is difficult to say how Nitrofix SR 30 Tablet and food will interact.
Interaction between Alcohol and Nitrofix SR 30 Tablet
Information about the interaction of Nitrofix SR 30 Tablet and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; monoket® (isosorbide mononitrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 544
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 716-718